Search Results
Revvity Sites Globally
Select your location.
*e-commerce not available for this region.
GSP Neonatal 17α-OH-progesterone kit
Congenital adrenal hyperplasia (CAH) is a genetic disorder and the most severe form of the disease can lead to a life threatening condition during the first weeks of life. The disease is caused by enzyme defects in steroid biosynthesis, the most frequent types being 21- and 11α-hydroxylase deficiency.
Products may not be licensed in accordance with the laws in all countries. Please check with your local representative for availability.
Product information
Overview
These types represent 95% of CAH cases and in both, the 17α-OH progesterone (17OHP), a precursor of cortisol, is increased. The determination of 17OHP is thus a useful screening method for 95% of all CAH cases.
GSP Neonatal 17α-OH-progesterone assay
The GSP Neonatal 17α-OH-progesterone assay is intended for the quantitative determination of 17OHP in dried blood spot specimens as an aid in screening newborns for CAH.
- Incubation time 3 h
- Sensitive, robust DELFIA chemistry for confidence in results
- Not affected by EDTA, citrate or heparin in samples
- All reagents are ready to use
- Contains reagents and plates for 1152 tests (12 plates)
Specifications
| Application |
Newborn Screening
|
|---|---|
| Assay Technology |
DELFIA
|
| Brand |
GSP®
|
| Calibration Standards |
Yes
|
| Detection Method |
DELFIA
|
| Disorders |
Congenital Adrenal Hyperplasia (CAH)
|
| Sample Type |
Dried blood spots
|
SDS, COAs, Manuals and more
Are you looking for technical documents for this product. We have housed them in a dedicated section., click on the links below to explore.
Related products
of 1
How can we help you?
We are here to answer your questions.
